Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated Tumors von Weinstein, J. N., Magin, R. L., Yatvin, M. B., Zaharko, D. S.

Volltext

Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic aci... von Hornung, RL, Back, TC, Zaharko, DS, Urba, WJ, Longo, DL, Wiltrout, RH

Volltext

Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells von COVEY, J. M, D'INCALCI, M, TILCHEN, E. J, ZAHARKO, D. S, KOHN, K. W

Volltext

Chloroquinoxaline sulfonamide : a sulfanilamide antitumor agent entering clinical trials von FISHERMAN, J. S, OSBORN, B. L, CHUN, H. G, PLOWMAN, J, SMITH, A. C, CHRISTIAN, M. C, ZAHARKO, D. S, SHOEMAKER, R. H

Volltext

DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells von DINCALCI, M, COVEY, J. M, ZAHARKO, D. S, KOHN, K. W

Volltext

Experimental Chemotherapy (L1210) With 5-Aza-2′-deoxycytidine in Combination With Pyran Copolymer (MVE-4), an Immune Adjuvant von Zaharko, Daniel S., Covey, Joseph M., Muneses, Concepcion C.

Volltext

Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light von CREEKMORE, S. P, ZAHARKO, D. S

Volltext

Flavone acetic acid (LM 975, NSC 347512): a novel antitumor agent von O'DWYER, P. J, SHOEMAKER, D, LEYLAND-JONES, ZAHARKO, D. S, GRIESHABER, C, PLOWMAN, J, CORBETT, T, VALERIOTE, F, KING, S. A, CRADOCK, J, HOTH, D. F

Volltext

Cyclopentenyl cytosine : interspecies predictions based on rodent plasma and urine kinetics von ZAHARKO, D. S, KELLEY, J. A, TOMASZEWSKI, J. E, HEGEDUS, L, HARTMAN, N. R

Volltext

Methotrexate Pharmacokinetics von Bischoff, K.B., Dedrick, R.L., Zaharko, D.S., Longstreth, J.A.

Volltext

Modulation of Deoxycytidine Metabolism In Vivo With High-Dose Thymidine in Mice von Zaharko, Daniel S., Covey, Joseph M.

Volltext

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients? von CASSIDY, J, KERR, D. J, SETANOIANS, A, ZAHARKO, D. S, KAYE, S. B

Volltext

Transport and Binding of Methotrexate In Vivo von Dedrick, R.L., Zaharko, D.S., Lutz, R.J.

Volltext

Preliminary Model for Methotrexate Pharmacokinetics von Bischoff, K.B., Dedrick, R.L., Zaharko, D.S.

Volltext

The Stimulation of Insulin Secretion in Dogs by Tris (Hydroxymethyl) Aminomethane von Zaharko, Daniel S.

Volltext

Reinvestigation of methotrexate metabolism in rodents von Zaharko, D.S., Oliverio, V.T.

Volltext

Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate von Weinstein, J N, Magin, R L, Cysyk, R L, Zaharko, D S

Volltext

Immunological Concepts and the Combination of Cyclophosphamide with 5-Aza-2′-Deoxycytidine on L1210 in Vivo von Zaharko, Daniel S.

Volltext

Methotrexate Tissue Distribution: Prediction by a Mathematical Model von Zaharko, D. S., Dedrick, R. L., Bischoff, K. B., Longstreth, J. A., Oliverio, V. T.

Volltext

The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides von Pinedo, H M, Zaharko, D S, Bull, J M, Chabner, B A

Volltext